PathCRISP is a CRISPR-Cas12-based platform for SNP detection, offering 100% specificity and sensitivity. Initially applied for Sickle Cell Anemia, it aims to expand to micronutrient deficiencies. The platform is cost-eff...
PathCRISP offers a field-ready diagnostic platform using CRISPR-Cas12 and PMA/EMA treatment to detect viable Tobamoviruses in seeds. It differentiates between viable and non-viable viruses, providing accurate seed health...